Measles Outbreak Reaches Highest Levels in Over 25 Years Across Europe and North America
In 2024, Europe and Central Asia reported 127,350 measles cases, the highest since 1997, sparking major health concerns and calls for increased vaccination efforts.
Health officials linked the soaring number of cases to the fact that in many countries vaccination rates had yet to return to pre-pandemic levels.
‘Wake-up call’: Measles cases doubled in Europe last year, say WHO and Unicef
The Guardian·7d
·ReliableThis source consistently reports facts with minimal bias, demonstrating high-quality journalism and accuracy.Leans LeftThis outlet slightly leans left.Vaccination rates in many countries are yet to return to pre-pandemic levels, increasing the risk of outbreaks.
Measles highest in 25 years in European region, WHO says
BBC News·8d
·ReliableThis source consistently reports facts with minimal bias, demonstrating high-quality journalism and accuracy.CenterThis outlet is balanced or reflects centrist views.After a drop in immunization coverage during the coronavirus pandemic, measles cases surged in 2023 and 2024, with vaccination rates in numerous countries still lower than what they were before COVID-19 hit.
Measles cases in Europe and Central Asia doubled last year to the highest reported level since 1997
Associated Press·8d
·ReliableThis source consistently reports facts with minimal bias, demonstrating high-quality journalism and accuracy.CenterThis outlet is balanced or reflects centrist views.
Summary
Measles cases in Europe and Central Asia doubled to 127,350 in 2024, the highest since 1997, primarily affecting children under 5. The outbreak reveals a decline in vaccination rates, exacerbated by the COVID-19 pandemic. Romania and Kazakhstan reported the highest infection rates. In the U.S., over 250 cases have emerged in several states, with concerns about misinformation affecting vaccination. Health officials urge renewed efforts to increase vaccine uptake, citing that 95% vaccination rates are necessary to prevent outbreaks.
Perspectives
Measles cases are surging globally, with over 127,350 cases reported in Europe and Central Asia in 2024, reflecting a significant public health crisis due to declining vaccination rates post-COVID-19.
The Measles, Mumps, Rubella (MMR) vaccine demonstrates 97% effectiveness, but vaccination coverage must exceed 95% to prevent outbreaks; low vaccine uptake, especially in areas with misinformation, is a serious concern.
Recent incidents in the U.S., including 250 cases and two fatalities, underscore the urgent need for vaccination and community immunity to combat the spread of measles.